Medtronic to buy up to $90M stake in heart valve developer Anteris [Yahoo! Finance]
Anteris Technologies Global Corp. (AVR)
Company Research
Source: Yahoo! Finance
Medtronic has agreed to buy up to $90 million worth of shares in Anteris Technologies Global, developer of a transcatheter aortic valve replacement device for patients with severe aortic stenosis. The purchase, in a private placement, is contingent on Anteris completing a proposed $200 million public stock offering, the company said Tuesday. Anteris said it will sell the shares to Medtronic at a price per share equal to the public offering price, subject to a minimum purchase of 16% of the number of common shares outstanding after the offering and a maximum purchase of 19.99%. Minimally invasive TAVR has surpassed open heart surgery as the preferred procedure for aortic valve replacement. Medtronic sells the Evolut TAVR system to treat severe aortic stenosis, a narrowing of the valve that makes it harder for the heart to pump blood. Edwards Lifesciences and Abbott also sell TAVR devices. Anteris' DurAVR device is a biomimetic valve designed to mimic the performance of a hea
Show less
Read more
Impact Snapshot
Event Time:
AVR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVR alerts
High impacting Anteris Technologies Global Corp. news events
Weekly update
A roundup of the hottest topics
AVR
News
- Retail investors who hold 25% of Anteris Technologies Global Corp. (ASX:AVR) gained 41%, institutions profited as well [Yahoo! Finance]Yahoo! Finance
- Anteris Technologies Global (NASDAQ:AVR) had its "buy" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital RaisesGlobeNewswire
- Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common StockGlobeNewswire
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public OfferingGlobeNewswire
AVR
Analyst Actions
- 1/23/26 - Lake Street Capital
AVR
Sec Filings
- 1/23/26 - Form 424B3
- 1/22/26 - Form 8-K
- 1/22/26 - Form 8-K
- AVR's page on the SEC website